A High-Throughput Screening Assay for mRNA Therapeutic Vaccines.

Key Points

• This high-throughput screening assay identifies potential mRNA therapeutics for vaccine development—significantly improving candidate evaluation.
• The system screened various mRNA constructs, successfully pinpointing several potent candidates among the tested 50.
• The approach involves innovative techniques to enhance the efficiency of vaccine candidate identification, ensuring rapid analysis.
• Such advancements may expedite the delivery of effective mRNA vaccines, promoting swift public health responses to infectious diseases.